Brief: Jilin Province Huinan Changlong Bio-Pharmacy Posts Qtrly Profit Attributable Of RMB36.6 Mln
Aug 14 (Reuters) - Jilin Province Huinan Changlong
Bio-pharmacy Co Ltd 8049.HK :
* QTRLY PROFIT ATTRIBUTABLE TO EQUITY HOLDERS RMB36.6
MILLION
VERSUS RMB37.5 MILLION
* QTRLY TURNOVER RMB151.6 MILLION VERSUS RMB156.4 MILLION
Source text for Eikon: ID:nHKS2lwR9B
Further company coverage: 8049.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Jilin Province Huinan Changlong Bio-pharmacy
See all newsJilin Changlong Bio-pharmacy interim profit rises on lower costs
Brief: Jilin Province Huinan Changlong Bio-pharmacy Posts H1 Revenue Of RMB 435 million
Brief: Jilin Province Huinan Changlong Bio-Pharmacy Profit For Year Attributable Rmb198.9 Million
Brief: Jilin Province Huinan Changlong Bio-Pharmacy Subscribes To ICBC Structured Deposit Product
Brief: Jilin Province Huinan Changlong Bio-Pharmacy Subscribes To ICBC Wealth Management Product For RMB50 MLN